Alaunos Therapeutics TCRT Growth Metrics (2009-2026)

NASDAQ TCRT
$0.87 -0.09 (-9.42%)
As of: Sep 30, 2026 · 1:50 PM EDT
Reported Financials

Alaunos Therapeutics Quarterly Growth Metrics

Periods 65 quarters
Latest Jun 2026

Alaunos Therapeutics reported asset growth of -67.98% for the quarter ended Jun 2026. These growth metrics cover 65 quarters of results from Dec 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2009 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
-31.42%-35.18%-33.84%-30.75%-40.80%-31.55%-42.77%-62.23%-71.13%-87.28%-87.59%-83.25%-81.74%-66.66%-64.88%1.22%4.90%7.66%-11.18%-67.98%
Assets Growth (3y)
19.42%-0.07%0.59%0.34%-17.04%-15.89%-37.40%-46.43%-51.06%-61.64%-63.91%-64.75%-68.52%-69.26%-70.78%-59.99%-61.90%-64.25%-66.17%-62.14%
Assets Growth (5y)
-0.58%-2.26%-2.10%-10.23%-10.39%-9.27%-11.07%-18.23%-21.88%-38.65%-40.87%-42.30%-50.37%-52.09%-59.65%-51.78%-53.20%-54.15%-57.03%-57.30%
Assets (QoQ)
6.55%-16.61%-10.41%-13.01%-8.91%-3.57%-25.10%-42.58%-30.39%-57.49%-26.94%-22.51%-24.11%-22.39%-23.05%123.35%-21.35%-20.35%-36.51%-19.49%
Capital Expenditures Growth (1y)Capex Growth (1y)
-81.61%-90.47%-95.96%-96.96%-96.22%-67.69%110.34%136.84%-92.86%
Capital Expenditures Growth (3y)Capex Growth (3y)
29.85%83.46%42.60%-5.25%-49.23%5.07%-50.83%-66.17%-92.08%-79.50%
Capital Expenditures Growth (5y)Capex Growth (5y)
11.78%34.36%-39.51%16.12%-28.70%-15.92%-16.47%-9.79%-64.16%-80.73%
Capital Expenditures (QoQ)Capex (QoQ)
-80.29%-2.97%-91.92%96.55%-75.44%728.57%-47.41%121.31%-99.26%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-32.31%-33.91%-31.77%-21.81%-58.78%-48.64%-65.60%-69.48%-68.41%-84.48%-82.36%-86.55%-85.91%-82.00%-92.30%16.89%15.15%26.95%10.97%-95.69%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
42.46%7.20%9.88%11.27%-24.66%-21.17%-48.40%-50.77%-55.50%-62.51%-65.40%-68.22%-73.62%-75.70%-83.28%-63.66%-62.85%-67.15%-75.30%-81.08%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-0.63%-1.27%0.55%-9.19%-14.84%-11.25%-14.39%-14.63%-17.75%-37.13%-39.58%-43.71%-54.72%-57.61%-71.55%-54.85%-57.24%-58.69%-67.66%-72.35%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
19.52%-17.08%-10.20%-12.14%-37.00%3.31%-39.84%-22.04%-34.79%-49.25%-31.62%-40.58%-31.67%-35.18%-70.76%802.51%-32.68%-28.53%-74.44%-64.97%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
81.61%90.47%95.96%96.96%96.22%74.09%20.69%-136.84%107.14%1,716.13%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
-29.85%-83.46%-42.60%5.25%49.23%2.39%64.47%66.17%26.00%33.87%77.93%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-11.78%-34.36%39.51%-16.12%28.70%19.55%31.27%9.79%14.94%77.21%80.73%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
80.29%2.97%91.92%-96.55%75.44%-564.29%75.27%-486.96%100.74%150,200.00%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
40.39%11.21%49.26%61.84%35.84%52.86%-20.73%14.47%-3.73%-3.58%79.57%75.99%87.75%91.98%59.73%58.30%-8.07%6.76%-33.55%57.20%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-4.03%-8.57%8.77%-0.41%17.46%15.00%1.80%20.63%26.52%24.32%49.97%57.21%56.63%66.05%53.68%55.92%48.41%57.38%52.10%65.01%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
7.46%-2.97%11.46%12.01%13.53%10.12%13.12%7.20%5.61%8.98%28.46%26.96%41.00%44.85%39.97%45.06%44.53%49.64%41.70%57.43%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
55.36%-57.94%48.63%-5.37%24.94%-16.03%-31.57%25.36%8.97%-15.86%74.04%12.31%53.54%24.20%-30.41%9.20%-20.40%34.60%-86.78%70.90%
EBITDA Margin Growth (1y)
0.52M44.64M-70.00M15.29M75.19M11.94M-1.11M
EBITDA Margin Growth (3y)
49.83M4.08M
EBITDA Margin Growth (5y)
-0.48M-51.65M0.06M
EBITDA Margin (QoQ)
-51.17M-7.05M59.68M14.49M-3.57M
EBIT Growth (1y)
-9.72%51.48%57.87%59.22%62.94%22.89%-6.46%13.55%-4.84%6.71%81.99%85.39%86.73%90.50%37.31%10.89%-3.22%-20.13%7.33%8.37%
EBIT Growth (3y)
-21.05%4.69%12.63%14.46%14.98%19.00%19.67%24.58%24.74%29.59%56.77%62.79%62.78%59.12%50.65%51.72%47.63%52.61%52.88%50.78%
EBIT Growth (5y)
-15.36%0.11%8.24%6.63%8.77%8.71%9.80%8.40%7.17%9.03%33.72%39.80%38.85%45.73%43.32%43.84%43.34%47.52%45.76%46.94%
EBIT Margin Growth (1y)
0.53M47.51M-71.74M17.04M77.60M11.96M-1.14M
EBIT Margin Growth (3y)
53.37M4.72M
EBIT Margin Growth (5y)
-0.49M-55.19M0.05M-7.66M
EBIT Margin (QoQ)
-54.69M-7.72M62.07M14.51M-3.57M
EBIT (QoQ)
1.52%50.44%17.79%-1.63%10.49%-3.11%-13.51%17.47%-8.54%8.25%78.09%33.07%1.37%34.35%-44.64%4.85%-14.24%23.59%-11.58%5.93%
EBT Growth (1y)
-11.90%48.16%54.62%55.95%59.96%20.21%-8.04%9.25%4.84%15.62%83.52%87.12%86.73%90.50%37.31%10.89%-3.22%-20.13%7.33%8.37%
EBT Growth (3y)
-21.85%2.56%10.44%12.24%12.19%16.25%17.25%21.36%24.74%29.59%56.77%62.79%63.02%60.01%51.85%52.95%49.29%54.17%54.26%52.79%
EBT Growth (5y)
-15.81%-1.22%6.87%5.18%6.99%6.85%8.18%6.07%7.17%9.03%33.72%39.80%38.85%45.73%43.32%43.84%43.34%47.52%45.76%46.94%
EBT Margin Growth (1y)
0.54M50.47M-70.93M19.71M77.60M11.96M-1.14M
EBT Margin Growth (3y)
57.15M5.54M
EBT Margin Growth (5y)
-0.50M-58.97M0.05M-8.48M
EBT Margin (QoQ)
-58.46M-8.53M62.07M14.51M-3.57M
EBT (QoQ)
-0.45%48.08%17.13%-1.92%8.70%-3.47%-12.22%14.40%4.27%8.25%78.09%33.07%1.37%34.35%-44.64%4.85%-14.24%23.59%-11.58%5.93%
EPS (Basic) Growth (1y)
-11.01%49.36%54.80%56.31%61.17%23.32%7.94%20.80%14.19%323.49%83.29%87.15%86.71%-103.28%36.21%11.08%24.57%1.09%22.95%37.56%
EPS (Basic) Growth (3y)
7.10%-26.84%18.34%20.21%54.39%23.37%22.92%25.19%28.21%42.08%58.88%64.57%64.62%61.70%53.88%55.11%55.86%58.31%56.54%58.53%
EPS (Basic) Growth (5y)
0.87%13.43%21.26%18.78%19.95%20.57%22.51%21.67%23.20%-41.33%39.10%44.70%59.56%49.47%45.34%45.56%48.26%51.04%49.10%52.30%
EPS (Basic) (QoQ)
-0.22%48.08%17.22%-1.45%10.93%-2.51%0.61%12.73%3.49%366.99%-107.43%32.88%0.18%34.16%-44.61%6.44%15.32%13.67%-12.65%24.18%
EPS (Diluted) Growth (1y)
12.40%49.36%55.71%56.31%61.17%23.32%7.94%20.80%14.19%323.49%83.29%87.15%86.71%-103.28%36.21%11.08%24.57%1.09%22.95%37.56%
EPS (Diluted) Growth (3y)
8.04%-26.84%21.32%23.14%56.93%23.37%27.26%30.87%33.66%42.08%59.16%64.57%64.62%61.70%53.88%55.11%55.86%58.31%56.54%58.53%
EPS (Diluted) Growth (5y)
10.41%13.43%21.29%19.42%21.15%20.57%22.95%22.13%23.67%-41.31%40.45%45.93%60.92%49.47%47.20%48.07%50.65%51.04%49.31%52.30%
EPS (Diluted) (QoQ)
-0.22%48.08%17.22%-1.45%10.93%-2.51%0.61%12.73%3.49%366.99%-107.43%32.88%0.18%34.16%-44.61%6.44%15.32%13.67%-12.65%24.18%
FCF Margin Growth (1y)
0.23M70.84M-67.26M13.64M72.37M15.31M-0.36M
FCF Margin Growth (3y)
75.94M4.74M
FCF Margin Growth (5y)
-0.16M-77.34M0.06M-6.51M
FCF Margin (QoQ)
-77.18M-6.57M54.68M14.97M-2.38M
Free Cash Flow Growth (1y)FCF Growth (1y)
44.97%25.56%51.35%64.66%38.08%53.21%-21.07%13.43%-3.51%-1.92%79.70%76.45%87.75%91.98%59.73%58.30%-8.07%6.59%-33.55%57.20%
Free Cash Flow Growth (3y)FCF Growth (3y)
-4.66%-9.69%8.68%-0.37%17.66%14.78%3.23%25.83%29.35%29.19%50.73%58.39%57.18%66.31%53.74%56.03%48.44%57.58%52.20%65.23%
Free Cash Flow Growth (5y)FCF Growth (5y)
7.03%-3.33%11.83%11.92%13.60%10.23%13.15%7.25%5.98%8.84%28.48%27.08%41.12%44.95%40.58%47.45%45.82%51.59%42.23%58.14%
Free Cash Flow (QoQ)FCF (QoQ)
57.36%-55.68%49.64%-5.71%25.29%-17.65%-30.31%24.41%10.68%-15.84%74.04%12.31%53.54%24.20%-30.41%9.20%-20.40%34.48%-86.44%70.90%
Gross Margin (QoQ)
Gross Profit (QoQ)
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
80.43%35.23%17.20%40.10%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
70.89%11.21%3.86%21.24%3.65%-13.51%30.45%
Net Cash Flow Growth (1y)NCF Growth (1y)
182.99%23.19%48.05%64.63%-155.18%107.98%-99.54%-131.89%22.90%-570.18%87.68%91.21%87.75%89.94%59.73%58.30%-8.07%6.59%-33.55%57.20%
Net Cash Flow Growth (3y)NCF Growth (3y)
55.04%-36.25%8.68%-1.33%-29.75%28.95%-29.48%-3.03%29.32%33.94%49.64%58.38%-27.08%66.45%53.74%56.03%53.26%-34.66%59.54%74.96%
Net Cash Flow Growth (5y)NCF Growth (5y)
24.95%-2.83%11.79%-17.80%8.36%15.92%4.74%-12.30%5.98%-17.07%28.48%26.66%-15.07%41.55%-14.97%47.44%45.80%51.40%41.47%58.13%
Net Cash Flow (QoQ)NCF (QoQ)
164.26%-204.62%50.23%-5.71%-0.27%115.13%-1,343.96%-22.84%66.66%7.70%67.41%12.31%53.54%24.20%-30.41%9.20%-20.40%34.48%-86.44%70.90%
Net Income Growth (1y)
-11.90%48.16%54.62%55.95%59.96%20.21%-8.04%9.25%4.84%15.62%83.52%87.12%86.73%90.50%37.31%10.89%-3.22%-20.13%7.33%8.37%
Net Income Growth (3y)
-21.85%2.56%10.44%12.24%12.19%16.25%17.25%21.36%24.74%29.59%56.77%62.79%63.02%60.01%51.85%52.95%49.29%54.17%54.26%52.79%
Net Income Growth (5y)
-15.81%-1.22%6.87%5.18%6.99%6.85%8.18%6.07%7.17%9.03%33.72%39.80%38.85%45.73%43.32%43.84%43.34%47.52%45.76%46.94%
Net Income (QoQ)
-0.45%48.08%17.13%-1.92%8.70%-3.47%-12.22%14.40%4.27%8.25%78.09%33.07%1.37%34.35%-44.64%4.85%-14.24%23.59%-11.58%5.93%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-11.90%48.21%54.59%56.19%61.07%22.34%-2.66%11.67%4.24%346.95%83.26%87.13%86.70%-103.28%36.21%6.91%-2.84%-20.35%6.24%9.42%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-6.80%-27.25%10.02%12.09%50.73%16.52%18.10%22.15%25.28%44.12%57.27%63.21%63.26%60.23%52.14%52.70%49.22%53.97%53.57%52.30%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-9.49%4.38%13.02%10.94%12.85%12.90%13.82%12.89%14.60%-34.97%34.00%40.08%56.69%45.72%43.29%43.71%43.60%47.68%45.82%46.96%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-0.28%48.12%17.01%-1.47%10.88%-3.48%-9.71%12.69%3.39%366.85%-107.44%32.88%0.18%34.16%-44.61%2.05%-10.28%22.95%-12.65%5.37%
Net Margin Growth (1y)
0.54M50.64M234.51M19.11M-228.03M11.46M-1.12M
Net Margin Growth (3y)
57.12M5.35M
Net Margin Growth (5y)
-0.48M-58.88M0.08M-8.21M
Net Margin (QoQ)
-58.40M-8.30M-243.00M14.00M-3.51M
Operating Income Growth (1y)Op. Inc Growth (1y)
-9.72%51.48%57.87%59.22%62.94%22.89%-6.46%13.55%-4.84%6.71%81.99%85.39%86.73%90.50%37.31%10.89%-3.22%-20.13%7.33%8.37%
Operating Income Growth (3y)Op. Inc Growth (3y)
-21.05%4.69%12.63%14.46%14.98%19.00%19.67%24.58%24.74%29.59%56.77%62.79%62.78%59.12%50.65%51.72%47.63%52.61%52.88%50.78%
Operating Income Growth (5y)Op. Inc Growth (5y)
-15.36%0.11%8.24%6.63%8.77%8.71%9.80%8.40%7.17%9.03%33.72%39.80%38.85%45.73%43.32%43.84%43.34%47.52%45.76%46.94%
Operating Income (QoQ)Op. Inc (QoQ)
1.52%50.44%17.79%-1.63%10.49%-3.11%-13.51%17.47%-8.54%8.25%78.09%33.07%1.37%34.35%-44.64%4.85%-14.24%23.59%-11.58%5.93%
Operating Margin Growth (1y)
0.53M47.51M-71.74M17.04M77.60M11.96M-1.14M
Operating Margin Growth (3y)
53.37M4.72M
Operating Margin Growth (5y)
-0.49M-55.19M0.05M-7.66M
Operating Margin (QoQ)
-54.69M-7.72M62.07M14.51M-3.57M
Profit After Tax Growth (1y)PAT Growth (1y)
-11.90%48.16%54.62%55.95%59.96%20.21%-8.04%9.25%4.84%15.62%83.52%87.12%86.73%90.50%37.31%10.89%-3.22%-20.13%7.33%8.37%
Profit After Tax Growth (3y)PAT Growth (3y)
-21.85%2.56%10.44%12.24%12.19%16.25%17.25%21.36%24.74%29.59%56.77%62.79%63.02%60.01%51.85%52.95%49.29%54.17%54.26%52.79%
Profit After Tax Growth (5y)PAT Growth (5y)
-15.81%-1.22%6.87%5.18%6.99%6.85%8.18%6.07%7.17%9.03%33.72%39.80%38.85%45.73%43.32%43.84%43.34%47.52%45.76%46.94%
Profit After Tax (QoQ)PAT (QoQ)
-0.45%48.08%17.13%-1.92%8.70%-3.47%-12.22%14.40%4.27%8.25%78.09%33.07%1.37%34.35%-44.64%4.85%-14.24%23.59%-11.58%5.93%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
53.91%6.94%-7.02%-16.67%-22.40%-22.68%-23.49%-25.41%-38.87%-99.98%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
105.49%115.25%120.10%122.58%121.92%96.80%27.75%7.88%-9.95%-94.20%-77.95%-77.93%-78.18%-78.27%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
69.85%66.97%55.78%55.55%53.94%47.52%44.69%40.20%32.71%-71.68%-58.17%-61.11%-62.52%-63.62%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
0.48%-6.18%-5.76%-6.21%-6.42%-6.52%-6.75%-8.56%-23.32%-99.96%-6.19%-9.89%-9.76%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.00M-0.00M-0.00M588.000.00M0.00M567.00-0.00M-0.01M-0.02M-0.03M-0.03M-0.01M0.01M0.02M0.02M0.02M0.00M-17.00-0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-513.00-888.00-0.00M22.00-46.00-692.00-0.00M-0.01M-0.01M-0.02M-0.03M-0.03M-0.02M-0.01M-0.01M-0.00M-0.00M-0.01M-0.01M-0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.01M0.01M0.01M-0.00M-0.00M-973.00-0.00M-0.00M-0.01M-0.02M-0.03M-0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-714.00587.00102.00613.000.00M-31.00-0.00M-0.00M-0.01M-0.01M-0.01M0.00M0.01M0.01M-0.00M0.01M0.00M-0.00M-0.00M-0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.01M-0.00M-0.00M-0.00M911.00422.00488.00-557.00-0.01M-0.02M-0.04M-0.03M-0.02M0.01M0.01M0.03M0.02M0.00M0.01M-0.03M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.04M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.02M-0.04M-0.04M-0.03M-0.01M-0.02M-0.01M-0.00M-0.01M-0.01M-0.04M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.01M0.01M-0.00M-0.01M-0.00M-0.00M-0.00M0.03M-0.02M-0.04M-0.04M-0.03M-0.01M-0.03M-0.01M-0.01M-0.01M-0.02M-0.04M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.00M0.00M-687.00-334.00-158.000.00M-621.00-0.00M-0.01M-0.01M-0.02M701.000.01M0.02M-0.01M0.01M0.00M-0.00M-0.01M-0.03M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.01M-0.01M-0.01M-0.00M178.000.00M0.00M-0.00M-0.01M-0.03M-0.04M-0.03M-0.02M0.02M0.02M0.03M0.02M0.00M0.00M-0.02M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.01M-0.00M-0.00M-0.01M-0.01M-0.01M-0.02M-0.03M-0.04M-0.04M-0.03M-0.01M-0.01M-0.00M-0.00M-0.01M-0.01M-0.03M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
-0.04M-0.04M-0.03M-0.01M-0.02M-0.01M-0.01M-0.01M-0.02M-0.03M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-0.00M-995.00-73.00335.00911.00417.00-646.00-0.00M-0.01M-0.01M-0.01M0.00M0.01M0.02M-0.01M0.01M0.00M-0.00M-0.01M-0.02M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.53M47.51M1.50M-18.66M-23.20M-71.74M-17.30M17.04M3.21M77.60M11.96M-3.81M13.22M-1.14M-8.36M-6.80M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.25M-51.56M-19.45M53.37M-3.83M-5.44M-6.76M4.72M-13.69M6.43M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.49M-55.19M-1.54M-1.21M0.05M-7.66M0.99M-19.79M-22.91M-75.80M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-54.69M53.63M0.34M1.26M-7.72M7.62M-19.83M-3.27M-56.26M62.07M14.51M-17.10M18.12M-3.57M-1.27M-0.06M3.77M-10.79M0.29M
Revenue Growth (1y)
631.41%450.00%-90.91%0.00%300.00%100.00%-25.00%
Revenue Growth (3y)
25.99%-35.15%
Revenue Growth (5y)
-24.27%-73.72%12.74%-63.05%
Revenue (QoQ)
-99.50%-99.62%0.00%300.00%-50.00%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
32.31%-36.14%-61.17%-81.29%-65.92%-4.36%6.68%-7.68%-10.15%-71.49%-81.10%-88.95%-88.98%-67.60%-60.47%83.17%276.25%200.00%107.35%32.97%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
17.01%10.27%-16.32%-18.05%-18.38%-18.16%-22.30%-18.05%-26.01%-44.16%-57.22%-73.27%-67.69%-55.46%-56.96%-42.83%-28.05%-34.81%-46.29%-35.44%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
3.27%-17.21%-15.87%-13.62%-17.25%-17.46%-24.29%-11.79%-13.28%-18.23%-34.77%-43.78%-44.25%-44.94%-48.84%-35.53%-30.01%-29.90%-42.26%-45.86%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-55.18%-61.32%-6.98%16.06%-18.38%8.54%3.76%0.44%-20.57%-65.56%-31.20%-41.28%-20.79%1.25%-16.05%172.06%62.70%-19.27%-41.98%74.47%
Total Debt Growth (1y)
-6.37%-30.49%-54.81%
Total Debt (QoQ)
-0.38%0.82%0.85%-7.56%-26.04%-34.46%

Alaunos Therapeutics Growth Metrics API

Pull Alaunos Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TCRT&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY